Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Scribd Logo
Upload

Welcome to Scribd!

  • 487 views

    Kinetics of Multiple Dosing

    Uploaded by

    HUNOOR SHAIK
    This document discusses approaches to designing optimal multiple dosage regimens for drugs. It describes three main approaches: empirical dosage regimens designed by physicians based on experience; individualized regimens based on a patient's pharmacokinetics; and regimens based on population averages using fixed or adaptive models. The key aspects in designing a regimen are maintaining therapeutic drug concentrations over time while minimizing fluctuations and toxicity.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    Kinetics of Multiple Dosing

    Uploaded by

    HUNOOR SHAIK
    487 views4 pages
    This document discusses approaches to designing optimal multiple dosage regimens for drugs. It describes three main approaches: empirical dosage regimens designed by physicians based on experience; individualized regimens based on a patient's pharmacokinetics; and regimens based on population averages using fixed or adaptive models. The key aspects in designing a regimen are maintaining therapeutic drug concentrations over time while minimizing fluctuations and toxicity.

    Original Description:

    Kinetics of multiple dosing

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    This document discusses approaches to designing optimal multiple dosage regimens for drugs. It describes three main approaches: empirical dosage regimens designed by physicians based on experience; individualized regimens based on a patient's pharmacokinetics; and regimens based on population averages using fixed or adaptive models. The key aspects in designing a regimen are maintaining therapeutic drug concentrations over time while minimizing fluctuations and toxicity.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    487 views4 pages

    Kinetics of Multiple Dosing

    Uploaded by

    HUNOOR SHAIK
    This document discusses approaches to designing optimal multiple dosage regimens for drugs. It describes three main approaches: empirical dosage regimens designed by physicians based on experience; individualized regimens based on a patient's pharmacokinetics; and regimens based on population averages using fixed or adaptive models. The key aspects in designing a regimen are maintaining therapeutic drug concentrations over time while minimizing fluctuations and toxicity.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    of 4

    Blophamacwuhcs Phomocoknekica BP604T

    Unil-y

    KinaticsMukbb DoAin9 Dr. Parjanya Shukla


    &
    Dr. M. P. 5Stngh Classe

    i oage Regimns-
    dingd Ki in which
    X
    DoA
    DoAa9e Ragiman as
    drug is taken
    mannir a

    * Tor dom drugs bk - analgesics, byþnokics, anhemahcs e

    aa Aingl doA may provids elfachva tuabmunk.

    toY Bomu ilnuMAs» drug ars uquired to bs taken on

    a epihva basis Or o period Hm

    So Jov succnlu Kraby , design o an ophimum


    mulhbl dosog Jug imen in nu cuma

    xAn 0phmum Mulipl dosage Ragiman is Ki on

    in which drug s odminiaBarad in uitablu doxs


    (by 0 uwiBablo xoule)wi bulliuknteqn hat thar
    QhAurAs maintenanu plasma con&nraion oim in
    Irabaukc toindouo or enkira dunahon of Karaby

    Apbroachto Duaign d DoaRegimen


    (0)Empivical Do»age Rigiman
    4 i dosignud by H phyaicion barad on

    empinical clinical daba, þarxonal expevienu and clinical


    obsvations
    (Tkis apbToach is nof vany accrata)
    ()Thdividualigad Doxag Rogiman - Dr. Parjanga Shuhla
    &
    i s monl occwnal approoch basad on Dr. M. P. ingh Clasaea

    hamatokinhes odrug in the individual patent

    xTh's abprooch is buitabl fov hospihalisad pokonts


    bud quls Rxpenaive
    )Doagq Kagimen on Populakon Avaragos
    Mast ofan sad approo ch

    basad on on o h two modals.

    a) fixod Modal
    Hara bopuwakon averoq phomacokinuhic þaromatava
    ad dirtkl to caludal dos 094 sagiman.

    Cb) Adophva Modid:


    X basud bastd on bot

    bopwahon,
    avArag phomacokinhic paromatsrs and
    bakont Voriak JLs Auh as wight, gge , ARX
    body Auuau 0rAa and known paHent
    pakophyxiolog Auch as xunal danasa

    Os ao Ths mag nituds o b o


    L
    Ropwic and toxic suspomsas dapends ubon doae aiza.
    h cadcuahon uquiTA Knowlidgs o amount of drug abaoTbed oqtar
    odminiaohon each do.
    xGrialar H dosaqe ie q7alr h lwchuahions
    btCss,max and Css, min Dr. Parjanya Shukla
    duing 2ach intarva doing Dr. M.P. Singh Classes

    9Tatar h chonus d toxiaity

    T
    Lorgs doss þrofilu
    0rimum lutuahon
    shouo boh Kerahuht
    and toxic xesponsa.
    msc
    ophrum donsprolks
    herabuheall
    sucusful
    MEC
    Smallur doaL prufilu
    min- utuahion
    but tnauliulznt
    henabeukrally

    Doaing. fraguny
    XTh dos intarval i calulated on th basis of

    half-fa d K dug
    X hs intarva intriased and doAe s unchan gtd

    max, min Cav dYRasAs


    and

    but Cmax/ Cmin increas s

    opbosit is obanvsd whn dos/ng ntavval ib uduad


    oT doing auancu hcreas ad
    A propiY balona b/w both doss Ai3 and
    Dr. Parjanya Shukla
    dosing d7 gunty s desirable &
    Dr. M.P. 3tngh Clases
    to atlain otsody staki comunhalHon wih minimum uchuaton
    and fo onsuT Kerafbeuhic efficay and dofky

    High dosing fngunuy


    tti)
    ln fluchuahan ku
    shows boh therapuhic
    and toxit uspomses.
    MsC
    Obhimum doning
    agueny (T ta)
    Knopubtally
    suluful
    MEC
    Les doning figunu
    (T> tiy)
    Lorgucbuahons
    Arabuhraly
    mL unAuCul
    By-Dr. mahendro PraBab Sin g |

    Drug Accwmulakon Duning Mulkplh Doaing

    You might also like